Handbook

56Focus 2011 | Exhibion | Parcipang CompaniesStand 42NHS ImprovementWorking with over 240 sites across England, NHSImprovement works with NHS organisations andclinical networks to help transform, deliver and buildsustainable improvements across the entire pathwayof care in cancer, diagnostics, heart, lung, stroke andaudiology services.With ten years practical improvement experience,NHS Improvement aims to develop sustainableeffective pathways and systems, share improvementresources and learning, increase impact and ensurevalue for money to improve the efficiency andquality of NHS services.With a focus on quality, productivity and innovation,NHS Improvement works closely with the NHSMedical board and Department of Health with allwork aligned to national priorities and supportingdelivery of key national strategies.With a continued focus on the delivery of qualityimprovements based on the latest evidence-basedpractice and a robust monitoring of performance,the work of NHS Improvement makes a significantpractical difference to services along the patientpathway and is clinically led and patient focused toachieve the best outcomes.Further information from:Iain Fletcher, Communications Director,NHS Improvement, 3rd Floor, St John’s House,East Street, Leicester LE1 6NBTel: 0116 222 5113 Fax: 0116 222 5101e-mail: iain.fletcher@improvement.nhs.ukWebsite: www.improvement.nhs.ukStand 41Nova BiomedicalThe design and manufacture of biosensors for use inPoint of Care Testing devices has been the specialityof Nova Biomedical for over 30 years. The NovaStatStrip® Glucose system provides laboratoryaccuracy in a POC setting. StatStrip® patentedmulti-well technology requires no calibration codes,has no known interferences including haematocrit,maltose, galactose, xylose, ascorbate etc and is easyto use. StatStrip® provides QC lock-out, bar-codedID, and full connectivity.Other StatStrip® meters include lactate for sepsismanagement and glucose with ketones offering themost accurate measurement of whole bloodketones for detection and management of DKA asper recent JBDS and BSPED guidelines. StatSensor-i®gives POC creatinine/eGFR results in 30 secondsoffering Radiologists, Oncologists, ICU and A&E anaccurate, reliable assessment of renal function. StatProfile® pHOx and pHOx Ultra uniquely offer acomprehensive critical care test menu including:blood gas, electrolyte, metabolite and co-oximetrymeasurements; uniquely urea, creatinine, ionisedmagnesium and total bilirubin are available on theUltra.Further information from:Linda McGough, Nova Biomedical,C3-5 Evans Business Centre, Deeside IndustrialPark, Deeside, Flintshire CH5 2JZTel: 01244 287087 Fax: 01244 287080e-mail: office@novabiomedical.co.ukWebsite: www.novabiomedical.comStand 39PerkinElmerPerkinElmer is a global company focused onimproving the health and safety of people and theirenvironment. From earlier medical insights andmore effective therapies to cleaner water and saferhomes, PerkinElmer touches the lives of millions ofpeople around the world every day.As the global leader in newborn screening andprenatal risk assessment, PerkinElmer has pioneeredthe application of tandem mass spectrometry innewborn screening. This technology enablesprograms to screen for several tens of disordersusing a single blood sample.Now, for clinical laboratories that wish to put thepower of mass spectrometry to work, the company’snew generation clinical MS/MS kits are designed tomeet present and future assay needs. The MS/MSSteroids kit supports measurement of 10 steroidanalytes in the same aliquot, while the new MS/MSVitamin D kit provides enhanced detection for25-OH-vitamin D /D3. Both assays are suitable foruse with most MSMS instruments.Further information from:Nick Withers, PerkinElmer, Chalfont Road,Seer Green, Beaconsfield HP9 2FXTel: 07876 394203e-mail: nick.withers@perkinelmer.comWebsite: www.perkinelmer.co.ukStand 29ScheBo Biotech UK LtdScheBo Biotech is proud of the scientific and clinicalevidence supporting our products. Our monoclonalantibody ScheBo Pancreatic Elastase-1 Stool Test('faecal elastase') is widely regarded as thenon-invasive “test of choice” for pancreatic exocrinefunction.